Second-line Hormonal Therapy for the Management of Metastatic Castration-resistant Prostate Cancer: a Real-World Data Study Using a Claims Database

We evaluated the efficacy of second-line hormonal therapy for treatment of metastatic castration-resistant prostate cancer (mCRPC) in a real-world retrospective study. We conducted a population-based real-world cohort study of 258 mCRPC patients between 2014 and 2018 using the Chang Gung Research Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jui-Ming, Lin, Cheng-Chia, Liu, Kuan-Lin, Lin, Cheng-Feng, Chen, Bing-Yu, Chen, Tien-Hsing, Sun, Chi-Chin, Wu, Chun-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060246/
https://www.ncbi.nlm.nih.gov/pubmed/32144327
http://dx.doi.org/10.1038/s41598-020-61235-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060246/
https://www.ncbi.nlm.nih.gov/pubmed/32144327
http://dx.doi.org/10.1038/s41598-020-61235-4

Ejemplares similares